Corona virus: Oxford vaccine trial stopped in India

Corona virus: Oxford vaccine trial stopped in India

Corona virus: Oxford vaccine trial stopped in India. The Serum Institute of India (SII), based in Pune, India, has currently stopped the trial of Oxford’s corona virus vaccine. Trial will be banned till further instructions from the Drug Controller General of India. This trial has been stopped due to security reasons.

Corona virus: Oxford vaccine trial stopped in India

The trial of the Corona vaccine being developed by Oxford University and AstraZeneca was stopped after a volunteer in the UK became ill. However, the CEO of Serum Institute said that the vaccine trial is going on in India. Subsequently, the Drugs Control General of India had issued a notice to the Serum Institute of India. And questioned why the serum did not inform the DGCI about the results of the ongoing trials in other countries.

Trials of the second and third phase of the Oxford vaccine are being conducted in 17 places in India. However, after receiving DCGI’s notice, Serum Institute has decided to stop the trial.

The first and second successful phases of the trial have raised hopes and many tie-ups around the world for mass production of the vaccine. In the third phase, the vaccine trials were extended to the US, Brazil, South America and India.

It has been reported that during the trial a volunteer in the UK was diagnosed with transverse myelitis. an inflammatory syndrome affecting the spinal cord, for which viral infection may be responsible. An independent investigation is being conducted to find the cause. The decision to resume the trial will be taken by the Medicine and Healthcare Products Regulatory Agency (MHRA).

According to scientists, such breaks are only part of the vaccine trials. A vaccine expert from Delhi AIIMS said, “On some occasions it happens that the patient becomes ill or sometimes even dies during the vaccine dose. This is a process and trials need to be stopped. Trial investigators are following the entire ethical standard.


Subscribe our news on Google News